{"sourcedb":"DevicePMAs@therightstef","sourceid":"P990004_S008","text":"Approval for marketing a pre-filled paste prepared from the powdered form of the absorbable gelatin sponge.  The device, as modified, will be marketed under the trade name surgiflo hemostatic matrix and is indicated for surgical procedures (except urologic and ophthalmic) for hemostasis, when control of capillary, venous and arteriolar bleeding by pressure, ligature and other conventional procedures is ineffective or impractical.","project":"consensus_PMA_Age_Indications"}